ERICA DEE: Open Payments
NPI 1881653905 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 72 payments from 21 companies in 2025. Trend: 2023 $619 · 2024 $1,544 · 2025 $1,660
Food & beverage: $1,626Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $393 |
| CSL Behring | 12 | $280 |
| Regeneron Healthcare Solutions, Inc. | 11 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| GC Biopharma USA, Inc. | 3 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Lilly USA, LLC | 3 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $53 |
| Pharming Healthcare, Inc. | 2 | $50 |
| Grifols USA, LLC | 2 | $48 |
Products named: FASENRA, Hizentra, DUPIXENT, AIRSUPRA, ALYGLO, CUVITRU, EBGLYSS, Haegarda.
Industry payments across MA — which companies pay providers there.
